Title:
セリチニブ製剤
Document Type and Number:
Japanese Patent JP7084955
Kind Code:
B2
Abstract:
The present disclosure relates to a new pharmaceutical composition comprising Ceritinib. Particularly it is directed to the tablet that is prepared by wet granulation, wherein povidone is used as a binder. Further feature of the composition is that the drug and the binder form the inner phase, whereas all other excipients are added in a powder form as an outer phase. This way, the sticking of the composition is prevented and sufficient tablet hardness can be reached.
Inventors:
Brueles, sebastian
Enthrin, Simon
Enthrin, Simon
Application Number:
JP2020046475A
Publication Date:
June 15, 2022
Filing Date:
March 17, 2020
Export Citation:
Assignee:
Novartis Age
International Classes:
A61K31/506; A61K9/20; A61K9/48; A61K47/32; A61K47/38; A61P35/00; A61P35/04; A61P43/00
Domestic Patent References:
| JP2010512329A | ||||
| JP2013526482A | ||||
| JP2011511818A |
Attorney, Agent or Firm:
Hiroshi Kobayashi
Eiji Katayama
Norio Omori
Eiji Katayama
Norio Omori